Eris Lifesciences Limited — Shareholders meeting

Eris Lifesciences Limited has announced the convening of a postal ballot to seek shareholder approval for specific corporate actions. This process replaces the traditional physical or electronic general meeting, allowing eligible investors to cast their votes remotely by post.

Shareholders are being asked to approve certain resolutions that the company's board has proposed. This method is typically used for routine or non-controversial matters, aiming to streamline the decision-making process and reduce administrative costs for the company.

Investors should review the explanatory statement attached to the postal ballot papers carefully. It is important to check the deadline for returning the ballot papers to ensure their votes are counted in the outcome of the meeting.